Literature DB >> 2147706

Mismatch of left ventricular function and infarct size demonstrated by technetium-99m isonitrile imaging after reperfusion therapy for acute myocardial infarction: identification of myocardial stunning and hyperkinesia.

T F Christian1, T Behrenbeck, P A Pellikka, K C Huber, J H Chesebro, R J Gibbons.   

Abstract

Quantitation of perfusion defect size using tomographic imaging with technetium-99m-hexakis-2-methoxy isobutyl isonitrile was performed at the time of hospital discharge in 32 patients with a first myocardial infarction who underwent successful coronary reperfusion within 8 h of the onset of chest pain. Reperfusion was accomplished with thrombolysis or primary coronary angioplasty. Radionuclide angiography was performed at discharge and 6 weeks later. There was a close correlation between perfusion defect size and values for ejection fraction and regional wall motion both at discharge (r = -0.80 and -0.75, respectively) and 6 weeks later (r = -0.81 and -0.81, respectively). There was no overall group difference in ejection fraction between the value at discharge and at 6 weeks; however, five patients had a significant increase (greater than or equal to 0.08) and six had a significant decrease (greater than or equal to 0.08) in ejection fraction. In patients with a significant increase at 6 weeks, ejection fraction was significantly lower at discharge than the value predicted from perfusion defect size (0.37 +/- 0.09 measured versus 0.47 +/- 0.13 predicted, p less than 0.05) and it improved at 6 weeks to near predicted values (0.51 +/- 0.07). In patients with a significant decrease at 6 weeks, ejection fraction was significantly higher at discharge than the value predicted from perfusion defect size (0.60 +/- 0.10 measured versus 0.50 +/- 0.10 predicted, p less than 0.05) and it decreased at 6 weeks to near predicted levels (0.51 +/- 0.09). Left ventricular ejection fraction at the time of hospital discharge is a potentially misleading index of the efficacy of reperfusion therapy for myocardial infarction. In a significant minority (34%) of patients this index does not accurately reflect perfusion defect size, apparently because of the effects of myocardial stunning and compensatory hyperkinesia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147706     DOI: 10.1016/0735-1097(90)90313-e

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  17 in total

Review 1.  Acute rest myocardial perfusion imaging for chest pain.

Authors:  Michael C Kontos; Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

Review 2.  Role of nuclear cardiac imaging in myocardial infarction: postinfarction risk stratification.

Authors:  John J Mahmarian; Girish Dwivedi; Tultul Lahiri
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

3.  Assessment of Regional Viability in the Infarct Zone Following Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 4.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

5.  Evaluation of a multicrystal gamma camera and rotating chair for tomographic studies of the heart.

Authors:  M K O'Connor; J Koss; C Caiati; R L Morin; T F Christian; R J Gibbons
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

6.  The impact of emerging guidelines on nuclear cardiology.

Authors:  R J Gibbons
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

7.  The influence of gating on measurements of myocardium at risk and infarct size during acute myocardial infarction by tomographic technetium 99m-labeled sestamibi imaging.

Authors:  T F Christian; M K O'Connor; R B Glynn; P J Rogers; R J Gibbons
Journal:  J Nucl Cardiol       Date:  1995 May-Jun       Impact factor: 5.952

8.  Tomographic and planar quantitation of perfusion defects on technetium 99m-labeled sestamibi scans: evaluation in patients treated with thrombolytic therapy for acute myocardial infarction.

Authors:  L A Mortelmans; F J Wackers; J L Nuyts; I A Scheys; T Brzostek; C W Schiepers; E E Lesaffre; P L Suetens; A M Verbruggen; F J Van de Werf
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

9.  Recovery of Left Ventricular Systolic Function and Clinical Outcomes in Young Adults With Myocardial Infarction.

Authors:  Wanda Y Wu; David W Biery; Avinainder Singh; Sanjay Divakaran; Adam N Berman; Gloria Ayuba; Ersilia M DeFilippis; Khurram Nasir; James L Januzzi; Marcelo F Di Carli; Deepak L Bhatt; Ron Blankstein
Journal:  J Am Coll Cardiol       Date:  2020-06-09       Impact factor: 24.094

10.  Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention.

Authors:  Roberto Sciagrà; Alessio Imperiale; David Antoniucci; Angela Migliorini; Guido Parodi; Giannetto Comis; Alberto Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.